CNTB Share Price Performance
US$0
-1.99 (-100.00%)
Price US$0
Share Pricen/a
Analysis Article • May 20
Connect Biopharma Holdings Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
CNTB Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Connect Biopharma Holdings Limited Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- -1.03
- 100.00%
- -27,727.90%
- 0%
About CNTB
- Founded
- 2012
- Employees
- 64
- CEO
- WebsiteView website
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
